Видео ютуба по тегу Idh1 Mutation

IDH Mutations in Cancer
IDH Mutations in Cancer
ICRN Webinar:
ICRN Webinar: "What is IDH1 mutated cholangiocarcinoma and what else can we do for it?”
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?
IDH1 mutation in haemato-oncology
IDH1 mutation in haemato-oncology
CCF Webinar: New Directions in Treating IDH1-Mutant Cholangiocarcinoma
CCF Webinar: New Directions in Treating IDH1-Mutant Cholangiocarcinoma
Deep dive into targeted therapies: understanding IDH1-mutant AML treatments
Deep dive into targeted therapies: understanding IDH1-mutant AML treatments
Clinical Response in Patients with IDH1 Mutation-Positive Hematologic Malignancies
Clinical Response in Patients with IDH1 Mutation-Positive Hematologic Malignancies
BRCAness in Malignant Gliomas: Missing the IDH1 Story - John M. Henson, M D, MBA
BRCAness in Malignant Gliomas: Missing the IDH1 Story - John M. Henson, M D, MBA
IDH Inhibitors for Cholangiocarcinoma
IDH Inhibitors for Cholangiocarcinoma
IDH1 Mutation in Cholangiocarcinoma - Kate Yen
IDH1 Mutation in Cholangiocarcinoma - Kate Yen
Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology and treatment
Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology and treatment
How Do IDH Mutations Cause Tumors?
How Do IDH Mutations Cause Tumors?
Implications of Rapid IDH1/IDH2 Testing for Liquid and Solid Tumors
Implications of Rapid IDH1/IDH2 Testing for Liquid and Solid Tumors
The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigation
The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigation
The Effect of IDH1 and IDH2 Mutations on the Progression of Glioblastoma
The Effect of IDH1 and IDH2 Mutations on the Progression of Glioblastoma
The impact of IDH mutated clones in NPM1+ AML
The impact of IDH mutated clones in NPM1+ AML
The prognostic impact of IDH mutations and the role of IDH inhibitors in MDS
The prognostic impact of IDH mutations and the role of IDH inhibitors in MDS
The Patient is In: Introduction to IDH-mutant cancers with Matthew Vander Heiden
The Patient is In: Introduction to IDH-mutant cancers with Matthew Vander Heiden
Ivosidenib for Advanced IDH1-Mutated CCA
Ivosidenib for Advanced IDH1-Mutated CCA
Early intervention with IDH inhibitors in IDH-mutated MDS: insights from clinical experience
Early intervention with IDH inhibitors in IDH-mutated MDS: insights from clinical experience